AbbVie, Johnson & Johnson, and Eli Lilly are noted as top holdings in specific healthcare ETFs.

The entities involved

• AbbVie →

  pharmaceutical company

  • AbbVie announced a joint development partnership with IGI, led by Lida Pacaud.Wed 17:17
  • Medicare eligibility rules affect AbbVie drug pricing, while the FDA regulates Creon's classification and approval for Medicare beneficiaries.Wed 16:42
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Microsoft and Alphabet are funding the AI boom, while TRACE pricing data is used for bond comparisons and both companies hold AAA ratings.Tue 09:15
  • Gardiner Harris's investigative reporting led to fraud fines against Bristol-Myers Squibb and a book dissecting Johnson & Johnson scandals.Tue 01:35
• Eli Lilly and Company →

  American pharmaceutical company

  • Nvidia is a top holding in VOO, which also holds Apple Inc. as a major position. Warren Buffett advises investing in S&P 500 ETFs, noting Eli Lilly as a key non-tech giant.Wed 21:56
  • Trade data and legislative control are currently influencing market sentiment and corporate operations.Wed 14:24

Related events

• Johnson & Johnson and Broadcom are noted as major holdings in the same investment fund, which also involves Apollo Global Management.Oct 23
• AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.Jun 8
• Procter & Gamble, Johnson & Johnson, Coca-Cola, and Verizon are discussed as income-generating companies referenced in dividend investment strategies.Aug 25
• AbbVie's CEO, Robert A. Michael, is linked to pre-IPO investments, with Benzinga reporting financial data and Kevin O'Leary commenting on strategies.Jun 7
• Ken Griffin made investment moves on October 18, 2026, buying shares of AbbVie and Abbott Laboratories, and boosting Eli Lilly shares.Oct 18